U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C25H28N8O3
Molecular Weight 488.5416
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PKI-179

SMILES

O=C(NC1=CC=NC=C1)NC2=CC=C(C=C2)C3=NC(=NC(=N3)N4[C@H]5CC[C@@H]4COC5)N6CCOCC6

InChI

InChIKey=WXUUCRLKXQMWRY-OYRHEFFESA-N
InChI=1S/C25H28N8O3/c34-25(28-19-7-9-26-10-8-19)27-18-3-1-17(2-4-18)22-29-23(32-11-13-35-14-12-32)31-24(30-22)33-20-5-6-21(33)16-36-15-20/h1-4,7-10,20-21H,5-6,11-16H2,(H2,26,27,28,34)/t20-,21+

HIDE SMILES / InChI

Molecular Formula C25H28N8O3
Molecular Weight 488.5416
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

PKI-179 is an orally efficacious dual PI3K/mTOR inhibitor, possessing antineoplastic activity. The key residues involved in binding of PKI-179 were Ala-805 in PI3Kγ and Ile-2163 in mTOR as they have lost maximum accessible surface area due to binding. By inhibiting the PI3K/mTOR signaling pathway, this agent may inhibit tumor cell proliferation and survival. Evaluation of in vivo efficacy in the nude mouse model bearing MDA-361 human breast cancer tumors showed pronounced tumor growth arrest when dosed above 10 mg/Kg.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: Q92569
Gene ID: 8503.0
Gene Symbol: PIK3R3
Target Organism: Homo sapiens (Human)
74.0 nM [IC50]
Target ID: P42345
Gene ID: 2475.0
Gene Symbol: MTOR
Target Organism: Homo sapiens (Human)
0.42 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Patents

Sample Use Guides

in rats: 10 mg/Kg
Route of Administration: Oral
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 02:31:12 GMT 2023
Edited
by admin
on Sat Dec 16 02:31:12 GMT 2023
Record UNII
CNN7Y60164
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PKI-179
Common Name English
N-(4-(4-(4-MORPHOLINYL)-6-(3-OXA-8-AZABICYCLO(3.2.1)OCT-8-YL)-1,3,5-TRIAZIN-2-YL)PHENYL)-N'-4-PYRIDINYLUREA
Systematic Name English
UREA, N-(4-(4-(4-MORPHOLINYL)-6-(3-OXA-8-AZABICYCLO(3.2.1)OCT-8-YL)-1,3,5-TRIAZIN-2-YL)PHENYL)-N'-4-PYRIDINYL-
Systematic Name English
PI 3-K/MTOR INHIBITOR III
Common Name English
Code System Code Type Description
DRUG BANK
DB13109
Created by admin on Sat Dec 16 02:31:12 GMT 2023 , Edited by admin on Sat Dec 16 02:31:12 GMT 2023
PRIMARY
NCI_THESAURUS
C90291
Created by admin on Sat Dec 16 02:31:13 GMT 2023 , Edited by admin on Sat Dec 16 02:31:13 GMT 2023
PRIMARY
FDA UNII
CNN7Y60164
Created by admin on Sat Dec 16 02:31:13 GMT 2023 , Edited by admin on Sat Dec 16 02:31:13 GMT 2023
PRIMARY
PUBCHEM
76958312
Created by admin on Sat Dec 16 02:31:13 GMT 2023 , Edited by admin on Sat Dec 16 02:31:13 GMT 2023
PRIMARY
EPA CompTox
DTXSID101026048
Created by admin on Sat Dec 16 02:31:12 GMT 2023 , Edited by admin on Sat Dec 16 02:31:12 GMT 2023
PRIMARY
ChEMBL
CHEMBL1258517
Created by admin on Sat Dec 16 02:31:12 GMT 2023 , Edited by admin on Sat Dec 16 02:31:12 GMT 2023
PRIMARY
CAS
1197160-28-3
Created by admin on Sat Dec 16 02:31:12 GMT 2023 , Edited by admin on Sat Dec 16 02:31:12 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY